Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Three days after Thanksgiving, Alex Bartlett ended up in the emergency room with excruciating and debilitating back pain.
Based on animal studies, researchers suggest that beta blockers may help.
One finding of the project was that, on average, the genome of cancer cells contains four or five “driver” mutations.
Last year, the FDA approved three new antibody-drug conjugates for treating cancer.
A new study developed a model categorizing the disease, and a treatment’s likelihood of success, based on the tumor’s site of origin.
The dog’s owner bought the ad to share the good news about his recovery and raise awareness about cancer in dogs.
Researcher interview with Jason Locasale
Scientists are combining immunotherapy agents to try to jump-start the immune system against solid tumors in children.
The study results also suggest that drugs targeting the two subsets could thwart the metastatic process in some cancers.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.
Researchers are using multiple strategies to tackle the same problem—how to activate T cells in people who don’t respond to immunotherapy.
While her response is not average, doctors say it represents a step forward for people with diffuse midline gliomas, a rare cancer.
A set of mouse studies shows that this dietary intervention could be groundbreaking for breast cancer research.
Scientists seek to design clinical trials to test therapies that are tailored to the specific genetic drivers of rare tumors.
The Human Tumor Atlas Network initiative will create maps of human tumors and their surrounding environment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.